Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 3

1.

Dose comparison study of pegylated interferon-alpha-2b plus ribavirin in naïve Japanese patients with hepatitis C virus genotype 2: a randomized clinical trial.

Kawaoka T, Kawakami Y, Tsuji K, Ito H, Kitamoto M, Aimitsu S, Kawakami H, Jeong SC, Imamura M, Aikata H, Takahashi S, Chayama K.

J Gastroenterol Hepatol. 2009 Mar;24(3):366-71. doi: 10.1111/j.1440-1746.2008.05650.x. Epub 2008 Nov 20.

PMID:
19032459
2.

Pegylated interferon alpha-2a and -2b in combination with ribavirin in the treatment of chronic hepatitis C: a systematic review and economic evaluation.

Shepherd J, Brodin H, Cave C, Waugh N, Price A, Gabbay J.

Health Technol Assess. 2004 Oct;8(39):iii-iv, 1-125. Review.

3.

Individualizing treatment duration in hepatitis C virus genotype 2/3-infected patients.

Mangia A.

Liver Int. 2011 Jan;31(1):36-41. doi: 10.1111/j.1478-3231.2010.02357.x. Epub 2010 Oct 12. Review.

PMID:
21040409

Supplemental Content

Support Center